Showing results (471-480 of 558) with videos related to
Sort By:
Pageof 56
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2003
Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated)Steven M Opal, Gary E Garber, Steven P LaRosa, et al.Contemporary Clinical Trials|March 27, 2017
Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatmentDonna M Evon, Carol E Golin, Paul Stewart, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 9, 2008
Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis CDavid R Nelson, Vinod Rustgi, Vijayan Balan, et al.The Plant Cell|September 23, 2015
Whole-Genome Resequencing Reveals Extensive Natural Variation in the Model Green Alga Chlamydomonas reinhardtiiJonathan M Flowers, Khaled M Hazzouri, Gina M Pham, et al.Journal of Clinical Gastroenterology|May 16, 2014
Sustained virologic response rates with telaprevir-based therapy in treatment-naive patients evaluated by race or ethnicitySteven L Flamm, Andrew J Muir, Michael W Fried, et al.Blood|July 23, 2013
IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCLHendrik Nogai, Sören-Sebastian Wenzel, Stephan Hailfinger, et al.Hepatology Communications|October 9, 2019
Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV-TARGET AnalysisKavita Radhakrishnan, Adrian M Di Bisceglie, K Rajender Reddy, et al.Proceedings of the National Academy of Sciences of the United States of America|April 12, 2022
Pathogen-induced biosynthetic pathways encode defense-related molecules in bread wheatGuy Polturak, Martin Dippe, Michael J Stephenson, et al.Clinical and Experimental Gastroenterology|December 7, 2016
HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infectionChristoph Sarrazin, Francesco Castelli, Pietro Andreone, et al.Annals of Hepatology|December 15, 2011
Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patientsDavid R Nelson, Stefan Zeuzem, Pietro Andreone, et al.Pageof 56